Incidence of anxiety in epilepsy during coronavirus disease (COVID-19) pandemic

Salari, Mehri; Etemadifar, Masoud; Gharagozli, Kurosh; Etemad, Koorosh; Ashrafi, Farzad; Ashourizadeh, Helia

doi:10.1016/j.yebeh.2020.107442

Cited by 21 publications

(19 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Hao et al reported that PWE with refractory epilepsy experience more psychosocial distress compared to healthy individuals 13 . However, other authors found that the anxiety level of PWE was not significantly higher than that of the general population 14 .…”

Section: Resultsmentioning

confidence: 78%

The impact of COVID-19 on patients with epilepsy

Silva

Barros

2021

Arq. Neuro-Psiquiatr.

View full text Add to dashboard Cite

Background: The COVID-19 pandemic and social distancing can have adverse impacts on adult people with epilepsy (PWE). Objective: To investigate the seizure frequency, the perceived well-being, and the presence of anxiety symptoms in PWE during the COVID-19 pandemic period. Methods: Data from a questionnaire on the repercussions of COVID-19 were analyzed in relation to the clinical variables of 114 PWE, with a significance level of p<0.05. Results: There were 26 cases of COVID-19 in PWE and/or family members (22.8%). During the pandemic period, 11 PWE (9.6%) reported an increase in seizures, but unrelated to COVID-19. Also, the number of crises in PWE with previous depressive disorders increased, with differences between epilepsies. Symptoms of depression, impaired well-being, and concern for their lifestyle were significant in PWE with a previous diagnosis of depression. Impaired well-being, increased anxiety, nervousness, and tiredness, and the concern with being infected were mentioned by a high number of PWE in the pandemic. Conclusion: Seizure frequency increased during the pandemic period, a finding associated with clinical variables of epilepsy. PWE with depression had worse perceived well-being. Changes in well-being and increased anxiety and nervousness were frequent in the pandemic.

show abstract

Section: Resultsmentioning

confidence: 78%

The impact of COVID-19 on patients with epilepsy

Silva

Barros

2021

Arq. Neuro-Psiquiatr.

View full text Add to dashboard Cite

show abstract

“…Ozamiz-Extebarria et al (2020) reported that, in Spain, younger individuals with chronic diseases complained more of symptoms related to anxiety and depression during the arrival of the virus and consequent confinement than the rest of the population [ 49 ]. Additionally, the presence of a chronic disease as a risk factor for anxiety and depression during the COVID-19 pandemic has been observed by Ping et al (2020, 29] in the general population in China and by Salari et al (2020) in patients with Parkinson’s Disease [ 48 ] and Epilepsy [ 51 ] in Iran. Participants with immunocompromised or immunosuppressed status were an exception in our sample as these individuals have more frequent intrusive symptoms than those who are not immune-deficient.…”

Section: Discussionmentioning

confidence: 99%

Incidence of PTSD and generalized anxiety symptoms during the first wave of COVID-19 outbreak: an exploratory study of a large sample of the Italian population

et al. 2021

View full text Add to dashboard Cite

Background During the COVID-19 pandemic, between March and May 2020, in Italy, people were asked to shelter in place and most had to put their life on hold, while news of the spread of the virus constantly were broadcasted. The change in habits and the potential exposure to a dangerous virus can be categorized as a catastrophic event, which are usually traumatic and therefore have psychological consequences for the people involved. Objective Assuming the COVID-19 pandemic as a possible traumatic event, this study aims to explore the contingent behavioural and psychological impact of COVID-19 spread and related lockdown on the Italian general population, through measuring anxiety and post-traumatic stress symptoms . Methods An ad hoc-survey was set up for the this exploratory research, including the standardized Italian versions of the Impact of Event Scale Revised (IES-R) and the Generalized Anxiety Scale (GAD-7), and ad hoc items concerning behavioural reactions due to the pandemic spread and related mass quarantine. Participants were recruited across convenient web-based and mobile app channels using a snowball sampling technique. Data was collected from March 25th to May 1st, 2020. Participants One-thousand one hundred and ninety-five individuals (851 women and 342 men) completed 60% or more of the survey and were considered for analyses. Mean age was 40 years (s.d. = 14.948). Participants resided in 78 Italian provinces (out of 107 territorial divisions), with 25.7% residing in the Milan province and 9.2% from the Monza and Brianza provinces, closest to the epicentre of the Italian outbreak. Results During the worst months of the first wave of the Pandemic, the Italian population suffered high level of distress (GAD-7 m = 6.89, s.d. = 5.08; IER-R mean score = 27.86, s.d. 17.46), respectively indicating mild presence of anxiety symptoms, and high levels of PTSD symptoms. Gender seems to be a discriminating variable with women scoring significantly higher than man, both for anxiety symptoms (H (1) = 82.91, p < .001) and all dimensions of PTSD symptoms (intrusion H (1) = 71.23, p < .001, avoidance H (1) = 61.28, p < .001), and hyperarousal (H (1) = 67.348, p < .001). People from Generations Y and Z show to be at higher risk of developing PTSD (V = .746, F (3,1041) =1017.19, p = .001) and GAD symptoms (F (3,1041) = 5.113, p = .002) than older generations. Conclusions Gender and generation appeared to be the most consistent risk factor for higher levels of generalized anxiety and PTSD symptoms in the current pandemic. Other variables – such as information seeking behaviours, parental and marriage status, chronic conditions – yielded less consistent evidence. Results indicate the need of including psychological interventions as a standard tool during the emergency management of a catastrophic events such as a pandemic.

show abstract

“…9 Relevant treatment should be continued and positive psychology management is beneficial. 10 More importantly, urinary urge/incontinence and increased motor fluctuations are commonly observed in PD patients, perhaps partly due to pharmacokinetic issues. 11 In our case, the patient was not able to tell the difference in her urinary symptoms but she had a urinary tract infection.…”

Section: Discussionmentioning

confidence: 99%

Management of a Parkinson’s disease patient with severe COVID-19 pneumonia

Liu

Zhu

et al. 2020

Therapeutic Advances in Chronic Disease

View full text Add to dashboard Cite

Elderly populations with underlying chronic diseases are more vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and have higher mortality. Parkinson’s disease (PD) is a neurodegenerative disease that occurs more often in elderly people. Currently, little is known about whether patients with PD are more susceptible to novel coronavirus disease 2019 (COVID-19) and whether the treatment of PD would affect the management of COVID-19 or vice versa. Here, we report a case of a PD patient with severe COVID-19 pneumonia in Wuhan, China. After diagnosis of COVID-19, this PD patient had worsening of motor symptoms, complicated with acute hypoxemic respiratory failure, urinary tract infection, and acute encephalopathy. In addition to treatment for COVID-19 and urinary tract infection, we adjusted anti-PD medicine by stepwise increasing of dose, resulting in better control of her mobility symptoms and non-motor symptoms.

show abstract

Incidence of anxiety in epilepsy during coronavirus disease (COVID-19) pandemic

Cited by 21 publications

References 11 publications

The impact of COVID-19 on patients with epilepsy

The impact of COVID-19 on patients with epilepsy

Incidence of PTSD and generalized anxiety symptoms during the first wave of COVID-19 outbreak: an exploratory study of a large sample of the Italian population

Management of a Parkinson’s disease patient with severe COVID-19 pneumonia

Contact Info

Product

Resources

About